Trials / Completed
CompletedNCT04343586
Blue Light Phototherapy
Development & Preliminary Clinical Validation Blue Light Phototherapy Systems for T-Cell
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
This study will use Blue-light Photo-therapy to treat patients with psoriasis vulgaris and Grover's Disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Blue light phototherapy | Phototherapy- Wavelength: 417±15 nm |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2021-12-20
- Completion
- 2022-09-22
- First posted
- 2020-04-13
- Last updated
- 2023-03-17
- Results posted
- 2023-03-17
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04343586. Inclusion in this directory is not an endorsement.